Education
About Us
Working with TipRanks
Follow Us
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ -98.61K | $ -42.47K | $ 0.00 |
| Operating Income | $ -15.66M | $ -19.42M | $ -18.67M | $ -6.15M | $ -726.60K |
| EBITDA | $ -16.19M | $ -17.97M | $ -17.47M | $ -6.11M | $ 0.00 |
| Net Income | $ -16.75M | $ -18.55M | $ -35.13M | $ -6.94M | $ -2.74M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.81M | $ 2.77M | $ 4.97M | $ 20.83M | $ 828.02K |
| Total Assets | $ 7.29M | $ 5.17M | $ 7.59M | $ 22.94M | $ 1.06M |
| Total Debt | $ 38.29K | $ 450.57K | $ 0.00 | $ 0.00 | $ 2.09M |
| Net Debt | $ -5.77M | $ -2.32M | $ -4.97M | $ -20.83M | $ 1.26M |
| Total Liabilities | $ 9.31M | $ 3.53M | $ 4.35M | $ 2.53M | $ 4.46M |
| Stockholders' Equity | $ -2.02M | $ 1.64M | $ 3.24M | $ 20.40M | $ -3.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -13.36M | $ -18.11M | $ -15.86M | $ -5.52M | $ -492.97K |
| Operating Cash Flow | $ -13.34M | $ -18.07M | $ -15.76M | $ -5.27M | $ -492.97K |
| Investing Cash Flow | $ -21.76K | $ -35.61K | $ -100.92K | $ -251.82K | $ 0.00 |
| Financing Cash Flow | $ 16.40M | $ 15.91M | $ 5.99K | $ 25.52M | $ 1.12M |
TransCode Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.